Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Notes Payables (2018 - 2023)

cbdMD's Notes Payables history spans 6 years, with the latest figure at $2492.0 for Q3 2023.

  • On a quarterly basis, Notes Payables fell 74.07% to $2492.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $2492.0, a 74.07% decrease, with the full-year FY2023 number at $2492.0, down 74.07% from a year prior.
  • Notes Payables hit $2492.0 in Q3 2023 for cbdMD, down from $4135.0 in the prior quarter.
  • Over the last five years, Notes Payables for YCBD hit a ceiling of $163858.0 in Q1 2020 and a floor of $2492.0 in Q3 2023.
  • Historically, Notes Payables has averaged $46791.5 across 5 years, with a median of $55639.0 in 2020.
  • Biggest five-year swings in Notes Payables: soared 82.06% in 2020 and later tumbled 88.0% in 2023.
  • Tracing YCBD's Notes Payables over 5 years: stood at $34404.0 in 2019, then surged by 64.44% to $56573.0 in 2020, then increased by 6.88% to $60468.0 in 2021, then plummeted by 83.86% to $9758.0 in 2022, then tumbled by 74.46% to $2492.0 in 2023.
  • Business Quant data shows Notes Payables for YCBD at $2492.0 in Q3 2023, $4135.0 in Q2 2023, and $7375.0 in Q1 2023.